News & Updates

$Testosterone treatment offers no protection against fractures in men with hypogonadism$

Testosterone treatment offers no protection against fractures in men with hypogonadism

14 Feb 2024

Testosterone treatment does not help lower the incidence of clinical fractures in middle-aged and older men with hypogonadism, according to a study.

Testosterone treatment offers no protection against fractures in men with hypogonadism

14 Feb 2024

Electroacupuncture: A non-pharma Tx option for central obesity?

14 Feb 2024 by

A Hong Kong study demonstrated the potential of electroacupuncture for the treatment of central or abdominal obesity.

Electroacupuncture: A non-pharma Tx option for central obesity?

14 Feb 2024

Semaglutide for weight management beneficial to Asians with overweight, obesity

14 Feb 2024

Treatment with semaglutide induces weight loss in Asians with overweight or obesity, regardless of the presence of type 2 diabetes, according to the phase IIIa STEP 7 study.

Semaglutide for weight management beneficial to Asians with overweight, obesity

14 Feb 2024

AI model improves thyroid cancer diagnosis

12 Feb 2024

An artificial intelligence (AI)-based model, dubbed AI-Thyroid, for the diagnosis of thyroid cancer demonstrates its utility in improving diagnostic performance and interobserver agreement, which could be helpful in less-experienced physicians, reports a study.

AI model improves thyroid cancer diagnosis

12 Feb 2024

Intensive lifestyle intervention reduces long-term variability in blood sugar, lipids

11 Feb 2024 by

For people with overweight or obesity and type 2 diabetes, intensive lifestyle intervention appears to minimize the spikes and drops in cardiovascular risk factors such as blood glucose and lipids.

Intensive lifestyle intervention reduces long-term variability in blood sugar, lipids

11 Feb 2024

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

11 Feb 2024

The glucagon/GLP-1 receptor dual agonist survodutide appears to be safe and induce weight loss in individuals with obesity, according to data from a phase II dose-finding trial.

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

11 Feb 2024

Reduced social isolation, loneliness helps people with obesity live longer

10 Feb 2024 by

Addressing social isolation and loneliness in people with obesity can counter their increased risk of death, according to a study.

Reduced social isolation, loneliness helps people with obesity live longer

10 Feb 2024

High saturated fat intake tied to poor low- and high-contrast visual acuity

10 Feb 2024

Increased saturated fat intake in young adults appear to exert detrimental effects on high-contrast (HC) and low-contrast (LC) visual acuity (VA), according to a study.

High saturated fat intake tied to poor low- and high-contrast visual acuity

10 Feb 2024

Sleeve gastrectomy, gastric bypass deliver low perioperative risk

09 Feb 2024 by

Two weight-loss surgical procedures, namely laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass, are both safe, with similarly low risk of complications during and immediately after the procedure, according to a study.

Sleeve gastrectomy, gastric bypass deliver low perioperative risk

09 Feb 2024

Brolucizumab in DME provides durable visual and anatomical improvements with favourable safety profile

08 Feb 2024 by

Anti–vascular endothelial growth factor (anti-VEGF) agents are currently recommended for patients with diabetic macular oedema (DME), but treatment regimens are associated with high medical burden that may compromise compliance and visual outcomes. At a Novartis-sponsored meeting, Professor Justus Garweg of the Swiss Eye Institute in Bern and Rotkreuz, Switzerland, shared personal experiences on advantages of the anti-VEGF, brolucizumab, in patients with DME while highlighting 2-year results of the pivotal phase III KESTREL and KITE trials.

Brolucizumab in DME provides durable visual and anatomical improvements with favourable safety profile

08 Feb 2024

News & Updates

Filter by Specialty:

Specialty:

Testosterone treatment offers no protection against fractures in men with hypogonadism

Testosterone treatment offers no protection against fractures in men with hypogonadism

Electroacupuncture: A non-pharma Tx option for central obesity?

Electroacupuncture: A non-pharma Tx option for central obesity?

Semaglutide for weight management beneficial to Asians with overweight, obesity

Semaglutide for weight management beneficial to Asians with overweight, obesity

AI model improves thyroid cancer diagnosis

AI model improves thyroid cancer diagnosis

Intensive lifestyle intervention reduces long-term variability in blood sugar, lipids

Intensive lifestyle intervention reduces long-term variability in blood sugar, lipids

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

Glucagon/GLP-1 receptor dual agonist for weight loss shows therapeutic potential

Reduced social isolation, loneliness helps people with obesity live longer

Reduced social isolation, loneliness helps people with obesity live longer

High saturated fat intake tied to poor low- and high-contrast visual acuity

High saturated fat intake tied to poor low- and high-contrast visual acuity

Sleeve gastrectomy, gastric bypass deliver low perioperative risk

Sleeve gastrectomy, gastric bypass deliver low perioperative risk

Brolucizumab in DME provides durable visual and anatomical improvements with favourable safety profile

Brolucizumab in DME provides durable visual and anatomical improvements with favourable safety profile